PD 117588
Code | Size | Price |
---|
TAR-T28314-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28314-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28314-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
PD 117588 is a quinolone against bacterial isolates from cancer patients. PD 117558 has a broad antimicrobial spectrum with excellent activity against all Gram-positive isolates (including methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci, Streptococcus faecalis and Group JK-corynebacteria). PD 117588 is also extremely active against Gram-negative bacilli with the exception of Pseudomonas aeruginosa against which ciprofloxacin was more active. PD 117588 has lower minimal inhibitory concentrations for most organisms tested than either imipenem or ceftazidime.
CAS:
99734-97-1
Formula:
C20H23F2N3O3
Molecular Weight:
391.419
Purity:
0.98
SMILES:
CCNCC1CCN(C1)c1c(F)cc2c(c1F)n(cc(C(O)=O)c2=O)C1CC1
References
1. Rolston KV, LeBlanc B, Gooch G, Ho DH, Bodey GP. In-vitro activity of PD
117558, a new quinolone against bacterial isolates from cancer patients. J Antimicrob Chemother. 1989 Mar;23(3):363-71. PubMed PMID: 2732120.
117558, a new quinolone against bacterial isolates from cancer patients. J Antimicrob Chemother. 1989 Mar;23(3):363-71. PubMed PMID: 2732120.